Daridorexant for Insomnia Nears Approval in Japan
A new drug application has been submitted in Japan for the approval of daridorexant, a dual orexin receptor antagonist for insomnia.
Stay updated with breaking news from Mochida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new drug application has been submitted in Japan for the approval of daridorexant, a dual orexin receptor antagonist for insomnia.
Researchers have developed a bacteria-based tool to test whether form follows function among organelles.
Scientists have long understood that parts of cells, called organelles, evolved to have certain shapes and sizes because their forms are closely related to how they function. Now, Johns Hopkins researchers have developed a bacteria-based tool to test whether, as the axiom goes, form follows function.
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd today announced the sale of its operating businesses in the Asia Pacific region , including...
^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating businesses in the Asia Pacific (ex-China) region ("Territory"), including assignment of PIVLAZ (clazosentan) and license rights to daridorexant in ...